Our Team

Dr. Taymaa May, MD MSc FRCSC
Clinical Director

Dr. May is a Gynecologic Oncologist at the University Health Network and Assistant Professor at the University of Toronto. She received her medical degree from McGill University in Montreal and went on to complete post-graduate training in Obstetrics and Gynecology at the University of Toronto. During her residency, Dr. May completed the Clinician Investigator Program and received an MSc from the Institute of Medical Sciences at the University of Toronto. Following residency, she completed a 3-year fellowship in Gynecologic Oncology at Brigham and Women’s Hospital/ Dana Farber Cancer Institute, Harvard Medical School in Boston, MA.

Dr. May has clinical training in the medical management of women with gynecological malignancies and surgical training in complex oncologic surgeries including pelvic, abdominal, laparoscopic and robotic surgery. Her research interests are in translational science and clinical trials in the field of ovarian cancer.

Gabrielle Ene, BSc (Honours)
GYN Biobank Manager, January 2020 - present
Clinical Research Analyst

Ms. Ene holds 4 years of research experience with the Princess Margaret Cancer Centre as part of the Gynecologic Oncology Research Program. She has an interest in understanding the clinical care provided to BRCA1/2 carriers and those carrying mutations in other risk genes. She is part of the Familial Ovarian Cancer Clinic (FOCC) and After Care Program, located at Women’s College Hospital. As the site coordinator, Gabrielle collaborates with the FOCC clinical team and key scientists to facilitate and develop a well-integrated clinical research program aimed at advancing the clinical care of those at a greater risk of developing ovarian cancer. As of January 2020, she will provide scientific oversight on study protocols, coordinate GYN sample requests and provide support to all research partners.  

Sharin Collins, BSc (Honours)
Clinical Research Study Assistant

Ms. Collins is a Clinical Research Study Assistant at the Princess Margaret Cancer Centre. She has an interest in gynecological cancers and annotated biospecimens that translate scientific discoveries into better patient diagnostics and therapies. Sharin has 5 years of experience in biobanking initiatives including patient recruitment, specimen procurement and data management.  

Operating Partner:
GU BioBank, University Health Network

The GU BioBank was founded in 2008 to facilitate the discovery and validation of novel biomarkers, aimed at delivering personalized medicine in Urology. The promise of liquid biopsies and longitudinal biospecimen collections in urologic cancer cohorts and healthy controls has further enhanced the relevance of this initiative. Establishment of a systematic and clinically-integrated approach to biospecimen procurement has facilitated research collaborations both nationally and internationally.

Former Team Members

Alicia Tone, PhD
Scientific Director, March 2018 – January 2020

Dr. Tone completed her PhD training in molecular biology at the University of Toronto, followed by a Post Doctoral Fellowship in ovarian cancer genomics at the BC Cancer Agency. As a Scientific Associate in the Division of Gynecologic Oncology at the Princess Margaret Cancer Centre from 2012-2020, she worked with Dr. May to oversee the scientific aspects of the GYN Biobank. Dr. Tone has 16 years of experience in the ovarian cancer field, with interests in understanding the unique genetic risk factors, cells of origin and clinical course of the most common histological types of epithelial ovarian cancer.